SRC and pulmonary fibrosis: Src inhibitor PP2 significantly reduced Src activation in bleomycin-treated lungs (Fig. 4D, lanes 6–10 versus lanes 1–5), supporting that Src inhibitor blocks Src activation and attenuates lung fibrosis in animal model of lung fibrosis.